Layman test Hotgen | Antigen test with approval as a self-test by the BfArM

The COVID-19 rapid antigen test delivers highly precise results in a few minutes, costs only a fraction of a PCR test and saves laboratory capacity. We offer you a corona test approved by the BfArM as a lay test. This test has the advantage that, in contrast to the PoC tests, the smear is taken in the anterior nasal cavity (approx. 1.5 cm deep). In addition, the Hotgen self-test is easy to use thanks to the application liquid pre-filled in the sample tube. The Hotgen Coronavirus 2019-nCoV antigen test is approved as a lay test by the BfArM (Federal Institute for Drugs and Medical Devices). This corona test can be carried out within 15 minutes and is easy to use thanks to detailed step-by-step instructions. This test kit is used for the qualitative in vitro determination of the Covid-19 antigen using a human nasal swab from the anterior nasal cavity. The test is used as a rapid test for people with suspected Covid-19 and can be used for renewed nucleic acid detection in patients after their discharge. The SARS-CoV-2 antigen rapid test is a one-step in vitro test based on immunochromatography. It is used for the rapid, qualitative detection of antigen against SARS-CoV-2 in anterio-nasal (front nose) smears in suspected COVID-19 persons in the first seven days after the onset of symptoms. The SARS-CoV-2 antigen rapid test does not serve as a basis for diagnosing or ruling out an infection. Sensitivity: 95.37% (indicates the probability that a positive test is really positive) Specificity: 99.13% (indicates the probability that a negative test is really negative) BfArM listed: 5640-S-057/21 (AT282 / 21) Beijing Hotgen Biotech Co., Ltd